Fong L Y, Farber J L, Magee P N
Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Carcinogenesis. 1998 Sep;19(9):1591-6. doi: 10.1093/carcin/19.9.1591.
Previous work has shown that sustained increased and decreased cell proliferation, induced by dietary zinc deficiency and caloric restriction respectively, influence the course of N-nitrosomethylbenzylamine (NMBA)-induced esophageal carcinogenesis in rats. The present study considered whether the increased cell proliferation and esophageal tumor incidence induced by zinc deficiency are reversed upon zinc replenishment. Weanling rats were maintained initially on a deficient diet containing 4 p.p.m. zinc. After 5 weeks, carcinogen-treated animals were given six intragastric doses of NMBA (2 mg/kg twice weekly). Controls were untreated. After the second NMBA dose, the rats were divided into three dietary groups. One group was continued on the deficient diet, while the other two groups were switched to diets containing either 75 or 200 p.p.m. zinc, with half of the members in each group fed ad libitum and half pair-fed with deficient rats. NMBA-untreated controls were similarly replenished. At various time points, esophageal cell proliferation was assessed in five animals from each group by immunohistochemical detection of cells in S phase, with in vivo 5-bromo-2'deoxyuridine labeling. At 11 weeks after the first dose, esophageal tumor incidence was greatly reduced, from 100% in the deficient group to 26 and 14% respectively in the replenished groups fed ad libitum 75 and 200 p.p.m. zinc and to 14 and 11% respectively in the replenished groups pair-fed 75 and 200 p.p.m. zinc. In addition, the number of tumors per esophagus was reduced from 9.93 +/- 4.25 in deficient rats, to a range of 0.11 +/- 0.31-0.30 +/- 0.54 in replenished animals. Following zinc replenishment, esophageal cell proliferation, as measured by labeling index (LI), the number of labeled cells and the total number of cells, was markedly decreased in NMBA-untreated and -treated esophagi as compared with those in corresponding deficient esophagi. Thus, the esophageal cell proliferation induced by zinc deficiency is reversed by zinc replenishment and replenished animals have a markedly lower incidence of esophageal tumors.
先前的研究表明,分别由饮食锌缺乏和热量限制诱导的细胞增殖持续增加和减少,会影响N-亚硝基甲基苄胺(NMBA)诱导的大鼠食管癌发生过程。本研究探讨了锌缺乏诱导的细胞增殖增加和食管肿瘤发生率在补锌后是否会逆转。将断奶大鼠最初饲养在含4 ppm锌的缺乏饮食中。5周后,用致癌物处理的动物接受6次胃内注射NMBA(2 mg/kg,每周两次)。对照组不进行处理。在第二次注射NMBA后,将大鼠分为三个饮食组。一组继续维持缺乏饮食,而另外两组分别改为含75或200 ppm锌的饮食,每组一半动物自由采食,另一半与缺乏饮食的大鼠配对饲养。未用NMBA处理的对照组也同样进行补锌。在各个时间点,通过免疫组织化学检测S期细胞,并采用体内5-溴-2'-脱氧尿苷标记法,对每组5只动物的食管细胞增殖情况进行评估。在首次注射后11周,食管肿瘤发生率大幅降低,缺乏饮食组从100%分别降至自由采食75 ppm和200 ppm锌的补锌组的26%和14%,以及配对饲养75 ppm和200 ppm锌的补锌组的14%和11%。此外,每只食管的肿瘤数量从缺乏饮食大鼠的9.93±4.25减少到补锌动物的0.11±0.31 - 0.30±0.54范围内。补锌后,与相应缺乏饮食的食管相比,未用NMBA处理和用NMBA处理的食管中,通过标记指数(LI)、标记细胞数和细胞总数衡量的食管细胞增殖明显降低。因此,锌缺乏诱导的食管细胞增殖可通过补锌逆转,且补锌动物的食管肿瘤发生率显著降低。